GenSight has been selected to present at the 4th annual Cell & Gene Therapy Investor Day, organized by the Alliance for Regenerative Medecine.

It is a full-day conference combining discussions between key opinion leaders, top analysts and senior executives in addition to presentations by the field’s most promising companies. Bernard Gilly, CEO of GenSight, will present the company.